Title : Pacritinib: a new agent for the management of myelofibrosis?

Pub. Date : 2015

PMID : 26389774






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Several other JAKIs are undergoing evaluation in the clinical trial setting and Pacritinib , a novel JAK2 and FLT3 inhibitor, is at an advanced stage of investigation with recent completion of a Phase III trial and another ongoing. 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene Janus kinase 2 Homo sapiens